Drug Topics staff

Hi, this is Gabrielle Ientile with Drug Topics®. Today I'm going to be talking to Heidi Polek, strategic program manager at doctor first, about chronic conditions and medication adherence amid COVID-19. Before we get into our topic, here's the latest news from DrugTopics.com.

The National Community Pharmacists Association (NCPA) is pressuring the Trump administration to eliminate pharmacy DIR fees that inflate drug costs for seniors and negatively impact independent community pharmacies.

In a letter to President Trump, NCPA CEO B. Douglas Hoey explained the viability of independent pharmacies, especially given the amplified instability of pharmacies amid the COVID-19 pandemic depends on DIR reform. Hoey cited media reports warning that drug pricing may be addressed with executive orders from the Trump administration seeking to know Next, the Safe Harbor protections for rebates paid by manufacturers to the PBMs owned by large insurance companies.

NCPA therefore stressed the necessity of DIR fee reform and effectively lowering prescription costs and protecting independent community pharmacies, which serve some of the nation's vulnerable populations on the basis of healthcare access. NCPA also clarified that in the end, it will be the patient who will be hurt the most. And that's the latest news from DrugTopics.com.

Now, here's my interview with Heidi Polek.

 Before we get into our topic today, can you give an introduction of yourself and your background in pharmacy?

 I'm a registered pharmacist of almost 31 years, 30 years and counting. I spent the majority of that in community pharmacy and have recently transitioned to work for DrFirst 3 years ago in healthcare IT.

 So can you talk about what we currently know about the prevalence of chronic health conditions in COVID-19 patients in the New York City area?

 What we're seeing, unfortunately, not only in New York City, but really all across the country and the world, is that those that have been impacted most by COVID do have comorbid conditions such as heart disease, and diabetes, as well as respiratory conditions.

 Can you explain the medical adherence rates that we were seeing prior to the pandemic and the consequences of non-adherence?

 Sure, so, before the pandemic, we were seeing adherence rates at sadly about only 50% for patients with chronic conditions. And as you can understand, obtaining your medications became a little bit more difficult. So we are expecting to see some reduction in that adherence, although it was interesting to see that the 

 actually showed an increase in adherence the months of January through March to respiratory medications, so I think those people that were experiencing respiratory conditions kind of had the foresight to go out and make sure that they got their respiratory meds so that they would not be as impacted by COVID. We're still monitoring adherence today as it relates to the pandemic and we can just keep our fingers crossed that we don't see too much of a dip.

 What changes are pharmacies having to adjust to related to medication adherence amid COVID-19, And what are some of the ramifications?

 Pharmacies have had to change their business model since COVID-19. It's very much a patient-facing business and patients just are not being able to make the trip in. So pharmacies are reaching out telephonically, they're using video chatting, all kinds of tools that DrFirst has that can help them reach out to patients. They're delivering medications more. Insurance companies have given patients greater access to their medications. They're really doing a lot of hands on with their patients to make sure that they're getting their medication.

 With many losing their jobs or out of work during this time is non-adherence also being related to being able to afford medications?

 Even in good times, patients, sadly could not always afford their medications. And what is really great is that DrFirst has a tool that helps patients understand patients, pharmacies and doctors actually understand the cost of medications. And we're able to work with them to make sure that they can find an affordable alternative. Speaking with your doctor or pharmacist can help you find additional sources. Outside of manufacturer coupons, here are charitable organizations that help pay for medications, and even drug manufacturers, so we're using those sources probably more than we were before.

 And are pharmacy seeing a lot of their clones with immunocompromising conditions avoiding going to their pharmacy?

 In addition to patients with those conditions, I think overall, they're just seeing a reduction from everybody. I think we're all concerned whether we have a medical condition or not, we're making less trips out and about. And so as I stated earlier, pharmacies have changed their business model. They've increased delivery and many organizations that may have charged for delivery in the past have made delivery free, they’re probably doing it more often and mail ordering it to patients, so they have definitely changed their business to bring the pharmacy to the patient.

 And can you expand on some of the services that DrFirst provides?

 Sure, we have a wealth of programs that we can help both at the prescriber level as well as the pharmacy level. We have a tool that sends notifications to patients to educate them about the prescription that they're about ready to fail. It offers adherence information. It offers cost saving information. We have our telehealth and secure texting platforms, all of which can be used to really educate patients, keep them in contact with people who can help them and really drive that adherence to medication.

 And how do you see DrFirst being different from other telehealth services that we're currently seeing?

 Our platform for telehealth is actually really an all in one type platform. We have secure messaging, we allow for document sharing, which is extremely important in this time. In addition to telehealth, it is very patient friendly, there is no app to download on the patient side; that can be a little cumbersome for elderly citizens who may be experiencing issues the time. So we're just user friendly. We have a really robust company behind it. A lot of hands on people here to help you with any solution you're looking for.

We can actually service any patient whether you have diabetes or not, whether you have extensive medical conditions are not, our platforms are here to really help anybody across the care continuum. We can even engage caregivers. So maybe you're not the actual patient yourself. We with our telehealth solution, we have a group telehealth that allows us to bring other individuals, with obviously the permission of the patient, into the conversation. So we can bring in a caregiver who may not even be in the same city as the patient, which is sadly, definitely what we're seeing today. People have not been able to come together like they have in the past to go to office visits with family members. Our solution will really bring anybody regardless of their condition assistance.

 So there have been some concerns that COVID-19 is bringing forth in people with immunocompromised conditions or comorbid conditions, increased stress, anxiety during this time. What have you seen on the effects of stress on disease outcomes in those with chronic conditions being exacerbated by COVID-19?

 We’re certainly still in the middle of this pandemic, so we're still measuring that. But the early reports have shown that patients of all kinds are seeing an increase in stress. That's why it's more important than ever to reach out. We're all feeling it. Don't stay isolated, use whatever technologies you have to make sure that you reach out to your doctor, to your pharmacy to your family members. So yes, unfortunately, stress is increased in patients with comorbid conditions, which can cause a decline in their status, so we're telling people stay connected. Help is out there for you.

 There's also been some concern about inappropriate use of some medications or also over the counter drugs promoted by some media or social media for COVID-19. Have you seen issues with that as well?

 Certainly, there have been reports that patients will go into pharmacies or their providers and ask them about this. As I always recommend, whether it's a pandemic time or not, if you hear something that piques your interest in taking a medication, you need to speak to a health care professional, you need to talk to your doctor, you need to talk to a pharmacist to ensure that that medication is appropriate. Just because it helps someone with one condition does not mean it's going to help you and it's definitely important. Do not ever take a medication without being prescribed by your doctor.

 What do you see as the biggest takeaways on medication adherence and the pharmacist’s role?

 The pharmacist is really the most accessible health care provider. So many studies show that we are visited by patients 10 to 20 times more often than a physician. We're very accessible. We're typically behind a counter or just phone call away. Pharmacists are at the forefront of medication adherence, and we are the medication experts. It's what we strive to do every day. Please, I tell people all the time, we're here for you reach out to us, we'll help you stay adherent.

 Great. Those are all the questions I have, is there anything that you wanted to add or think that we missed before we wrap up?

 Every time I do these interviews, I can't help but stress enough that this is really a very stressful time for everyone, whether you have a medical condition or not, and we really just want you to stay connected. So do that in any way, shape or form that you can and it's just really exciting that here at DrFirst, we have those tools to help connect patients, prescribers, pharmacies, really anybody in the healthcare world and, you know, just hope that those tools are being used to the best of their ability.

 Heidi, thank you so much for joining me today.

Expert Interviews

Heidi Polek, strategic program manager at DrFirst, discusses with Drug Topics the impact that the COVID-19 pandemic is having on chronic conditions and medication adherence.

Expert Interview: Medication Adherence Amid COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has infected an estimated 24,495,232 individuals worldwide, and approximately 5.9 million Americans. The latest COVID-19 related news includes the Department of Health and Human Services (HHS) permitting pharmacists to order and administer COVID-19 vaccines and MJH Life Sciences™ hosting an upcoming webinar concerning the convergence of flu season and SARS-CoV-2 infections.

Here’s a roundup of the latest coronavirus-related news:

MJH Life Sciences COVID-19 Coalition to Host Live Webinar on Dual Flu, COVID-19 Threats

To kick off its partnership with top health care experts, the newly launched 

 will host its inaugural webinar event exploring dual threats as flu season and COVID-19 converge.

"Battling Dual Threats: Flu and COVID-19 Converge," a free, live, 1-hour webinar, will be broadcasted on Tuesday, September 15, at 6 p.m. EDT.

Oncology Pharmacists Adapt to Serve Patients Amid Pandemic

The COVID-19 pandemic has undeniably placed a significant burden on patients with cancer receiving chemotherapy and other medications and services.

However, oncology pharmacists quickly adapted, learning new ways to communicate with patients, schedule visits and treatments, and re-evaluate their medications regimens.

HHS Permits Pharmacists to Order and Administer COVID-19 Vaccines

HHS has authorized state-licensed pharmacists to order and administer, and state-licensed or registered pharmacy interns under the supervision of the pharmacist to administer, COVID-19 vaccines to individuals ages 3 or older, according to an announcement.

Articles

Here's this week's coronavirus-related news you should know.

Coronavirus News Roundup: Pharmacists Authorized to Administer COVID-19 Vaccines, MJH Life Sciences to Host Webinar on Dual Flu, COVID-19 Threats

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has infected an estimated 

 individuals worldwide, and approximately 6.1 million Americans. The latest COVID-19 related news includes AstraZeneca’s investigational vaccine expanding into a phase 3 clinical trial and a survey by NCPA gauging pharmacy plans for administering a COVID-19 vaccine.

COVID-19 Vaccine AZD1222 Moves to US Phase 3 Trial

AstraZeneca’s investigational COVID-19 vaccine candidate, AZD1222, has expanded into a phase 3 clinical trial, according to a press release.

The US trial, called D8110C00001, is funded by the Biomedical Advanced Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID). The NIAID-supported COVID-19 Prevention Network will participate in the trial.

Survey: Most Pharmacies Polled Plan to Administer COVID-19 Vaccines

A new survey conducted by NCPA suggests that most pharmacies plan to offer a COVID-19 immunization service when a vaccine becomes available.

Eighty-six percent of respondents said they plan to offer the COVID-19 vaccines in their pharmacies when they hit the marketplace, according to the survey of nearly 800 community pharmacy owners/managers.

FDA Issues Emergency Use Authorization to New 15-Minute COVID-19 Antigen Test

Officials with the FDA have issued Emergency Use Authorization (EUA) for Abbott’s BinaxNOW COVID-19 Ag Card rapid test for the detection of COVID-19, according to a press release.

BinaxNOW delivers results in 15 minutes and will be sold for $5, Abbott said. The test, which is approximately the size of the credit card, is highly portable and easy to use, with no equipment required.

Here's this week's coronavirus-related news.

Coronavirus News Roundup: AstraZeneca Vaccine Moves to Phase 3 Trial, Survey Shows Most Pharmacists Plan to Administer COVID-19 Vaccine

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has infected an estimated 24,495,232 individuals worldwide, and approximately 5.9 million Americans. The latest COVID-19 related news includes the FDA issuing Emergency Use Authorization (EUA) for Abbott’s BinaxNOW COVID-19 Ag Card antigen test, ASHP providing principles for the development and distribution of a future vaccine, and a study demonstrating a link between individuals with metabolic syndrome and COVID-19 deaths.

Abbott’s BinaxNOW COVID-19 Ag Card rapid test produces results in 15 minutes.

Officials with the FDA have issued an EUA for Abbott’s BinaxNOW COVID-19 Ag Card rapid test for the detection of COVID-19, according to a press release.

ASHP Outlines Tenets for COVID-19 Vaccine Rollout and Oversight

ASHP issued its recommended principles for the development, distribution, allocation, and oversight of an eventual COVID-19 vaccine.

Will Drive-Up Flu Vaccinations Be Prevalent This Fall?

As the COVID-19 pandemic unfolded, national pharmacy chains and some independents quickly stepped in and offered to be testing sites for the coronavirus. At many CVS and Walgreens stores, for example, individuals can drive up and receive a COVID-19 swab test.

Now, drug stores are parlaying that same philosophy into making influenza vaccinations more convenient and safe during the pandemic.

Metabolic Syndrome Linked to Increased Risk of COVID-19 Mortality

Individuals with metabolic syndrome who were hospitalized for COVID-19 were more likely to experience worse outcomes.

Patients with a combination of high blood pressure, obesity, and diabetes who are hospitalized with COVID-19 may be more likely to die from the disease, according to a new study.

Here's the coronavirus-related news from this week that you should know.

Author | Drug Topics staff

Articles

Expert Interview: Medication Adherence Amid COVID-19

Coronavirus News Roundup: Pharmacists Authorized to Administer COVID-19 Vaccines, MJH Life Sciences to Host Webinar on Dual Flu, COVID-19 Threats

Coronavirus News Roundup: AstraZeneca Vaccine Moves to Phase 3 Trial, Survey Shows Most Pharmacists Plan to Administer COVID-19 Vaccine

Coronavirus News Roundup: FDA Issues EUA for Rapid Antigen Test, ASHP Releases COVID-19 Vaccine Guidelines